Comparison Between Haparin and Herodin in HD
ConditionHaemodialysis
Trial statusNot yet recruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18-70
SponsorBasma Rabiey
About this trial
The goal of this study is to compare the efficacy and drawbacks of Heparin and Hirudin in Haemodialysis patients. The main question it aims to answer is:
which drug is more safe in Haemodialysis?
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patient age between 18:70
Haemodialysis duration less than 6 months
Agree to participate in the study
Disqualifiers
AKI
patients with impaired coagulation profile
Decompensated liver disease
Trial design
Design model
Single group
Treatments tested in this trial
Heparin
DrugComparison between heparin and hirudin
Treatment groups
98 Participants
are divided into 1 treatment groupGroup A: Heparin and HirudinExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Number of bleeding events and efficacy of dialysis during dialysis
patients will be investigated with aPTT before and after each of the following sessions (HD1, HD4, HD8), CBC/ week, number of clotting events, number of bleeding tendency, duration of fistula closure, to assess anticoagulant efficacy , and BUN, Serum creatinine, urea reduction ratio to assess dialysis efficacy.
Time frame
BaselineLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Basma Rabiey
Lead sponsor
Assiut University
Sponsor institution
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: